Arkolith/Insider Trading/TCRX/Form 4

Zdraveski Zoran

See RemarksTScan Therapeutics, Inc. (TCRX) · full profile →Form 4 · filed Feb 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2025Grant(A)250K—$0250K
Jan 12, 2024Grant(A)53K—$053K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-018131) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML